Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Append modifier 59 Distinct procedural service to the second initial service
For the broader pipeline context around these compounds, see our investigational peptide drugs for diabetes and obesity reviews 2019-2026 guide
Both compounds in the stack ship at 99% HPLC purity with mass-spec-verified identity, separate batch-specific certificates of analysis, and fast domestic Canadian shipping
Loargys : Immedica advances enzyme replacement for ARG1-D under accelerated approval Loargys On February 23, Immedica Pharma secured accelerated approval for Loargys (pegzilarginase-nbln) injection for hyperargininemia in adults and pediatric patients aged 2 years and older with arginase 1 deficiency, in conjunction with dietary protein restriction
US$ 23.36
US$ 20.49
US$ 23.83
